CSIMarket

Product Service News

MKS Instruments Driving Innovation and Commitment Amidst Strategic Financial Maneuvers and ESG Initiatives

July 29, 2024

In an era where corporate responsibility and technological advancement intertwine, MKS Instruments, Inc. (NASDAQ: MKSI) stands as a beacon of innovation and commitment. The company’s recent moves from unveiling its 2024 Environmental, Social, and Governance (ESG) Report to a substantial financial maneuver involvin...

Business Update

AtriCure Innovation on Display at Prestigious Global Growth and Healthcare Crossroads Conferences

July 29, 2024

AtriCure: Innovation on Display at Prestigious Global Growth and Healthcare Crossroads Conferences In the rapidly advancing world of medical technology, AtriCure, Inc. (Nasdaq: ATRC) continues to steer the ship of innovation with its groundbreaking contributions to surgical treatments and therapies. Specializing in ...

Product Service News

Revamping the Road How Wearable Devices are Steering the Future of Automotive Innovation

July 29, 2024

Wearable Devices Drive Innovation in the Automotive IndustryIn a groundbreaking move that heralds a new era for both technology and transportation, leading European automobile manufacturers are embracing wearable devices as a transformative element within the sector. The intersection of these two industries is prov...

Product Service News

AIM ImmunoTech Unveils Promising Data in Clinical Trials for Triple-Negative Breast Cancer

July 29, 2024

In a significant development for the field of oncology, AIM ImmunoTech Inc. (NYSE American: AIM) has announced the release of the latest segment of its CEO Corner, where the company’s Chief Executive Officer, Thomas Equels, elaborates on the positive findings from a Phase 1 clinical trial. This trial investigates ...

Financing Agreement

LeddarTech Secures More Financial Flexibility with Additional Waiver Under Credit Facility

July 29, 2024



Quebec City-based automotive software company, LeddarTech Holdings Inc. (LeddarTech), recently announced it has entered into a Tenth Amending Agreement, also known as the Waiver, with Fédération des caisses Desjardins du Québec (Desjardins). This agreement pertains to the Amended and Restated Financing ...

Our most Popular Articles
Partnership

Tiziana Life Sciences Pioneering a Nasal Revolution in Immunomodulation

February 21, 2025

In a strategic move that underscores its commitment to innovation in the biopharmaceutical sector, Tiziana Life Sciences has announced a collaborative agreement with Renaissance Lakewood, LLC, a notable player in Contract Development and Manufacturing Organizations (CDMO) specializing in nasal drug delivery. This pa...

Product Service News

In the digital visualization sphere, Matterport is pioneering a transformation that melds the allure of anc...

December 30, 2024

Exploring the Future: Matterport s Fusion of Heritage and Innovation in 2024 In the digital visualization sphere, Matterport is pioneering a transformation that melds the allure of ancient wonders and the marvel of contemporary advancements. As the year 2024 unfolds, Matterport has emerged at the forefront, not just...

Product Service News

Arcutis and Sato Forge Path for Revolutionary Dermatological Breakthroughs in Japan with Topical Roflumilast Collaboration

February 28, 2024

Arcutis and Sato: Revolutionizing Dermatological Solutions through Strategic Collaboration and Licensing Agreement for Topical Roflumilast in JapanIn a groundbreaking move, Arcutis, a leading dermatology-focused biopharmaceutical company, and Sato, a renowned Japanese pharmaceutical company, have joined forces in a ...

Company News
Business Update

AtriCure Innovation on Display at Prestigious Global Growth and Healthcare Crossroads Conferences

July 29, 2024

AtriCure: Innovation on Display at Prestigious Global Growth and Healthcare Crossroads Conferences In the rapidly advancing world of medical technology, AtriCure, Inc. (Nasdaq: ATRC) continues to steer the ship of innovation with its groundbreaking contributions to surgical treatments and therapies. Specializing in ...

Product Service News

Revamping the Road How Wearable Devices are Steering the Future of Automotive Innovation

July 29, 2024

Wearable Devices Drive Innovation in the Automotive IndustryIn a groundbreaking move that heralds a new era for both technology and transportation, leading European automobile manufacturers are embracing wearable devices as a transformative element within the sector. The intersection of these two industries is prov...

Contract

Verizons Strategic Moves Modernizing Infrastructure and Embracing Sustainability

July 29, 2024

In a rapidly evolving technological landscape, Verizon Business has made significant strides to ensure both operational excellence and sustainability. Recently, the announcement of a $77.7 million task order to modernize the National Weather Service (NWS) network infrastructure highlights Verizon s commitment to sup...

Company News
Clinical Study

s for appointing Dr. Steven B. Heymsfield as the Principal Investigator for its Phase 2b clinical trial of enobosarm....

July 29, 2024
Company News
Product Service News

CytoSorbents Launches Unified Digital Presence A Bold Step Towards Collaborative Healthcare Innovation

July 29, 2024
Company News
Clinical Study

NewAmsterdam Pharmas Obicetrapib Shows Promising Results in Phase 3 BROOKLYN Trial for Heterozygous Familial Hyperch...

July 29, 2024
More Company News
Clinical Study

Neflamapimods Potential to Alter Disease Progression in Dementia with Lewy Bodies Insights from the AscenD-LB Trial

July 29, 2024
Clinical Study

Ventyx Biosciences Faces Setback as VTX958 Trial Fails to Meet Primary Endpoint for Crohn’s Disease Treatment ...

July 29, 2024
Management Announcement

WillScot Mobile Mini demonstrates promising first quarter results and enhances market positioning

July 29, 2024
Partnership

Advancing Breast Cancer Detection iCAD and Windsong Radiology Harness AI Technology

July 29, 2024
Product Service News

Cerence Drives the Future of Automotive AI Transforming In-Car Experiences with Smart and Smart Eye Collaborati...

July 29, 2024
Product Service News

GARR Selects Infinera’s GX Series to Boost Italys Research and Education Network Capacity

July 29, 2024
Product Service News

DZS Strengthens Optical Transport with Remote In-Band Management on Saber 4400 Platform at Fiber Connect 2024...

July 29, 2024
Clinical Study

Grifols, a global leader in the production of plasma-derived medicines, has recently received approval from...

July 29, 2024
Financing Agreement

Securing Success: Achieve Life Sciences Extends Loan With Silicon Valley Bank, Paving the Way for Innovation

July 29, 2024
Announcement

STMicroelectronics Announces Status of Common Share Repurchase Program

July 29, 2024
Related News
Business Update

Sarepta Therapeutics Scheduled to Announce Second Quarter 2024 Financial Results on August 7

Business Update

D-Wave Quantum Inc. Shapes the Future of AI with New Quantum Cloud Enhancements Amid Government Support and Promisi...

Stocks
Clinical Study

Unveiling the Therapeutic Potential of Inflammasome Inhibitors ZyVersa Therapeutics Promising Developments

Licensing Agreement

Venus Concepts Regulatory Triumph Leveraging Canadian Approval to Transform the Aesthetic Market Landscape ...

Product Service News

NurseMagic Sees Unprecedented Adoption Among Nursing Professionals Across the Globe

Business News
Product Service News

AIM ImmunoTech Unveils Promising Data in Clinical Trials for Triple-Negative Breast Cancer

In a significant development for the field of oncology, AIM ImmunoTech Inc. (NYSE American: AIM) has announced the release of the latest segment of its CEO Corner, where the company’s Chief Executive Officer, Thomas Equels, elaborates on the positive findings from a Phase 1 clinical trial. This trial investigates ...

Financing Agreement

LeddarTech Secures More Financial Flexibility with Additional Waiver Under Credit Facility



Quebec City-based automotive software company, LeddarTech Holdings Inc. (LeddarTech), recently announced it has entered into a Tenth Amending Agreement, also known as the Waiver, with Fédération des caisses Desjardins du Québec (Desjardins). This agreement pertains to the Amended and Restated Financing ...

Financing Agreement

Calidi Biotherapeutics Receives Financial Boost to Revolutionize Cancer Therapies

Calidi Biotherapeutics Secures $3 Million Investment from Dr. Ronald Rigor for Nova Cell Subsidiary Development and Oncology Pipeline Expansion
San Diego-based biotechnology company, Calidi Biotherapeutics, has announced a strategic investment of $2 million from Dr. Ronald Rigor into its newly established subsid...

Product Service News

LPL Financial Strengthens Its Advisor Network with New Independent Practices, Welcoming Visionaries into the Fo...

SAN DIEGO, July 29, 2024 LPL Financial LLC (Nasdaq: LPLA) has made waves in the financial advisory landscape with a series of strategic acquisitions that bolster its independent advisor network. The latest announcement highlights the onboarding of Jerry Rizza, a seasoned financial advisor who previously managed a...

Product Service News

MKS Instruments Driving Innovation and Commitment Amidst Strategic Financial Maneuvers and ESG Initiatives

In an era where corporate responsibility and technological advancement intertwine, MKS Instruments, Inc. (NASDAQ: MKSI) stands as a beacon of innovation and commitment. The company’s recent moves from unveiling its 2024 Environmental, Social, and Governance (ESG) Report to a substantial financial maneuver involvin...

Our Most Popular Articles
Partnership

Tiziana Life Sciences Pioneering a Nasal Revolution in Immunomodulation

In a strategic move that underscores its commitment to innovation in the biopharmaceutical sector, Tiziana Life Sciences has announced a collaborative agreement with Renaissance Lakewood, LLC, a notable player in Contract Development and Manufacturing Organizations (CDMO) specializing in nasal drug delivery. This pa...

Product Service News

In the digital visualization sphere, Matterport is pioneering a transformation that melds the allure of anc...

Exploring the Future: Matterport s Fusion of Heritage and Innovation in 2024 In the digital visualization sphere, Matterport is pioneering a transformation that melds the allure of ancient wonders and the marvel of contemporary advancements. As the year 2024 unfolds, Matterport has emerged at the forefront, not just...

Product Service News

Arcutis and Sato Forge Path for Revolutionary Dermatological Breakthroughs in Japan with Topical Roflumilast Collaboration

Arcutis and Sato: Revolutionizing Dermatological Solutions through Strategic Collaboration and Licensing Agreement for Topical Roflumilast in JapanIn a groundbreaking move, Arcutis, a leading dermatology-focused biopharmaceutical company, and Sato, a renowned Japanese pharmaceutical company, have joined forces in a ...

More News
Business Update

AtriCure Innovation on Display at Prestigious Global Growth and Healthcare Crossroads Conferences

AtriCure: Innovation on Display at Prestigious Global Growth and Healthcare Crossroads Conferences In the rapidly advancing world of medical technology, AtriCure, Inc. (Nasdaq: ATRC) continues to steer the ship of innovation with its groundbreaking contributions to surgical treatments and therapies. Specializing in ...

Product Service News

Revamping the Road How Wearable Devices are Steering the Future of Automotive Innovation

Wearable Devices Drive Innovation in the Automotive IndustryIn a groundbreaking move that heralds a new era for both technology and transportation, leading European automobile manufacturers are embracing wearable devices as a transformative element within the sector. The intersection of these two industries is prov...

Contract

Verizons Strategic Moves Modernizing Infrastructure and Embracing Sustainability

In a rapidly evolving technological landscape, Verizon Business has made significant strides to ensure both operational excellence and sustainability. Recently, the announcement of a $77.7 million task order to modernize the National Weather Service (NWS) network infrastructure highlights Verizon s commitment to sup...

Clinical Study

s for appointing Dr. Steven B. Heymsfield as the Principal Investigator for its Phase 2b clinical trial of enobosarm....

Veru Inc. Engages Investors at BTIG Virtual Biotechnology Conference and Makes Progress with Enobosarm Clinical Trials for High-Quality Weight Loss Veru Inc. (NASDAQ: VERU), a late clinical-stage biopharmaceutical company headquartered in Miami, Florida, is at the forefront of innovation in the healthcare sector. On...

Product Service News

CytoSorbents Launches Unified Digital Presence A Bold Step Towards Collaborative Healthcare Innovation

In an era where digital presence is paramount for growth and engagement, CytoSorbents Corporation, a leading medical technology company specializing in critical care, has taken a significant leap forward by unveiling a newly redesigned and unified website. This initiative not only reflects the company’s commitment...

Clinical Study

NewAmsterdam Pharmas Obicetrapib Shows Promising Results in Phase 3 BROOKLYN Trial for Heterozygous Familial Hyperch...

NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia In a significant advancement in the treatment of hypercholesterolemia, NewAmsterdam Pharma has released promising topline data from its...

Clinical Study

Neflamapimods Potential to Alter Disease Progression in Dementia with Lewy Bodies Insights from the AscenD-LB Trial

In recent years, the need for effective therapies targeting neurodegenerative diseases, specifically those within the spectrum of dementia, has reached an urgent peak. Among them, Dementia with Lewy bodies (DLB) stands out due to its complex clinical features and profound impact on patients and caregivers alike. A n...

Clinical Study

Ventyx Biosciences Faces Setback as VTX958 Trial Fails to Meet Primary Endpoint for Crohn’s Disease Treatment ...

Phase 2 Trial of VTX958 Fails to Meet Primary Endpoint in Crohn’s Disease Patients: Implications for Ventyx BiosciencesIn the realm of gastroenterology and inflammatory bowel diseases, the importance of therapeutic options cannot be overstated, particularly in complex conditions such as Crohn s disease. Ventyx B...

Management Announcement

WillScot Mobile Mini demonstrates promising first quarter results and enhances market positioning



WillScot Mobile Mini Holdings Corp, a leading provider of total space solutions, announced the consolidation of its portfolio of brands under the unified name, WillScot. This strategic move aims to strengthen the company s market presence and streamline its offerings for enhanced customer experience. In ad...

Partnership

Advancing Breast Cancer Detection iCAD and Windsong Radiology Harness AI Technology

In a significant development in the field of medical imaging, iCAD, a company specializing in artificial intelligence (AI) solutions, has announced a strategic commercial agreement with Windsong Radiology. This partnership marks the deployment of the ProFound AI Breast Health Suite, aimed at enhancing mammography ca...

Product Service News

Cerence Drives the Future of Automotive AI Transforming In-Car Experiences with Smart and Smart Eye Collaborati...

Revolutionizing the Driving Experience: How Cerence is Innovating In-Car AI Technology Through Key Partnerships In an age where technology continues to intertwine with everyday life, Cerence Inc. (NASDAQ: CRNC), a leader in AI solutions for the automotive industry, is setting the stage for the next generation of in-...

Product Service News

GARR Selects Infinera’s GX Series to Boost Italys Research and Education Network Capacity

GARR, Italy s premier research and education network, has taken a significant step towards upgrading its optical infrastructure. The organization has chosen Infinera s GX Series ICE6 800G coherent solution to double the capacity of its network, GARR-T. This move is set to enhance data transmission and connectivity a...

Product Service News

DZS Strengthens Optical Transport with Remote In-Band Management on Saber 4400 Platform at Fiber Connect 2024...

Revolutionizing Optical Communications: DZS Unveils Groundbreaking Remote In-Band Management at Fiber Connect 2024 In a landscape where cutting-edge technology and digital transformation reign supreme, DZS continues to set the pace with its groundbreaking advancements in optical transport and edge management. At the upcoming Fiber Connect 2024, DZS is poised to showcase a revolutionary solution that promises to redefine the economics and capabilities of edge transport. By introducing remote in-band management for 100G/400G optical transport on the innovative Saber 4400 platform, DZS not only disrupts traditional economic models but also enhances the operational efficiency and performance of next-generation optics.The Saber 4400 platform is a testament to DZS s commitment to pioneering technologies that drive progress in the optical transport sector. This breakthrough solution addresses the perennial challenges faced by network operators, offering a compact and robust platform that can be managed remotely. This is particularly significant as it mitigates the need for manual intervention, thus reducing operational expenses and expediting deployment timelines.

Clinical Study

Grifols, a global leader in the production of plasma-derived medicines, has recently received approval from...

Expansion of XEMBIFY® Label in the U.S. Augments Treatment Options for Primary Humoral Immunodeficiencies Grifols, a global leader in the production of plasma-derived medicines, has recently received approval from the United States Food and Drug Administration (FDA) for an expanded label for XEMBIFY® (immune globu...

Financing Agreement

Securing Success: Achieve Life Sciences Extends Loan With Silicon Valley Bank, Paving the Way for Innovation

Achieve Life Sciences Secures $20M Loan Refinancing with Silicon Valley Bank, Extending Maturity Date to 2027
Achieve Life Sciences, a prominent late-stage pharmaceutical company specializing in smoking cessation and nicotine dependence, has recently announced a significant milestone in its financial operations....

Announcement

STMicroelectronics Announces Status of Common Share Repurchase Program

STMicroelectronics: Navigating Market Dynamics and Corporate Performance Amidst a Share Repurchase InitiativeIn a recent disclosure, STMicroelectronics N.V. reported significant developments regarding its common share repurchase program, reflecting its commitment to enhance shareholder value during a period of econ...



Previous News 1. Page 339. Page 340. Page 341. Page .... 388. Page .... 438. Page NEXT 
Previous News


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.